
No results matched your search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
MESO | NASDAQ | USD | Real-time | |
MEOBF | OTC Markets | USD | Delayed | |
MSB | Sydney | AUD | Delayed |
Mesoblast Limited hasannounced that it has enteredinto a subscription agreement worth $110M (A$138M) with the issue of 60M shares in a private placement led by...
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, today announced...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Buy | Buy | Sell | Strong Sell | Strong Sell |
Technical Indicators | Neutral | BUY | BUY | Strong Sell | Strong Sell |
Summary | Neutral | Buy | Neutral | Strong Sell | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Abandoned Baby Bullish | 15 | Current | |||
Belt Hold Bullish | 15 | Current | |||
Upside Gap Three Methods | 1H | Current | |||
Bullish Engulfing | 5H | Current | |||
Completed Patterns | |||||
Bullish doji Star | 15 | 2 | Mar 05, 2021 21:15 | ||
Bullish Engulfing | 1M | 4 | Nov 20 | ||
Falling Three Methods | 1M | 5 | Oct 20 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
NASDAQ | 9.17 | 9.40 | 9.45 | 218,973 | -0.11% | USD | 05/03 | ||
OTC Markets | 1.88 | 0.00 | 0.00 | 0 | +0.00% | USD | 02/03 | ||
Sydney | 2.320 | 2.320 | 2.330 | 3,640,074 | -2.11% | AUD | 05/03 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
FBN Holdings | 7.10 | 7.10 | 6.85 | +0.05 | +0.71% | 26.50M | 05/03 | ||
MTN Nigeria | 160.20 | 160.20 | 160.20 | -9.80 | -5.76% | 643.20K | 05/03 | ||
Guaranty Trust Bank | 31.20 | 31.05 | 30.90 | -0.50 | -1.59% | 20.83M | 05/03 | ||
Zenith Bank | 25.30 | 25.40 | 24.95 | 0.00 | 0.00% | 46.85M | 05/03 | ||
UBA | 7.95 | 7.95 | 7.85 | 0.00 | 0.00% | 23.30M | 05/03 | ||
Access Bank | 7.90 | 7.85 | 7.70 | +0.10 | +1.28% | 10.47M | 05/03 | ||
Dangote Sugar | 16.90 | 16.90 | 16.40 | +0.40 | +2.42% | 1.98M | 05/03 | ||
Lafarge Africa | 22.20 | 22.20 | 21.80 | +2.00 | +9.90% | 1.65M | 05/03 | ||
STANBIC IBTC Bank | 44.00 | 44.00 | 44.00 | +4.00 | +10.00% | 82.37K | 05/03 | ||
Oando Plc | 2.65 | 3.00 | 2.65 | -0.25 | -8.62% | 4.05M | 05/03 |
Mesoblast Limited is engaged in the development of regenerative medicine products. The Company’s regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells. Its allogeneic, off-the-shelf cell product candidates target advanced stages of diseases with high and unmet medical needs. The Company’s portfolio of Phase III product candidates comprises RYONCIL (remestemcel-L) for steroid-refractory acute graft versus host disease (acute GVHD), REVASCOR for advanced chronic heart failure (CHF) and MPC-06-ID for chronic low back pain due to degenerative disc disease. The Company's product candidate, MPC-150-IM, is in Phase III trials for the treatment of both advanced and end-stage CHF. The Company has conducted Phase II trial of MPC-300-IV in patients with biologic-refractory rheumatoid arthritis. The Company is developing MPC-25-Osteo for spinal fusion.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review